AMANDA DURYEA: Open Payments
NPI 1790284529 · INDIANAPOLIS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$740 in 29 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $538 · 2025 $740
Food & beverage: $740
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $222 |
| Shionogi Inc | 4 | $178 |
| Inspire Medical Systems, Inc. | 1 | $110 |
| ViiV Healthcare Company | 3 | $77 |
| Insmed, Inc. | 3 | $48 |
| Gilead Sciences, Inc. | 2 | $43 |
| Aimmune Therapeutics, Inc. | 2 | $40 |
| Merck Sharp & Dohme LLC | 1 | $22 |
Products named: Fetroja, MAVYRET, INSPIRE, DOVATO, Arikayce, VOWST, APRETUDE, DALVANCE.
Industry payments across IN — which companies pay providers there.
